Table 3.

Comparison of various indicators in thyroid and non-thyroid nodule patients among female diabetic and non-diabetic patients

Influencing factors	Diabetic patients			Non diabetic patients
	Non-thyroid nodule patients	Thyroid nodule patients	P	Non-thyroid nodule patients	Thyroid nodule patients	P
Insulin	38.04 ± 11.89	35.83 ± 8.98	0.6610	35.65 ± 8.53	37.21 ± 10.05	0.0893
25-hydroxyvitamin D	26.2 ± 6.89	21.13 ± 12.66	0.4436	16.73 ± 13.29	20.58 ± 13.73	0.0062
LH	63.93 ± 19.26	53.19 ± 26.08	0.4376	39.4 ± 32.74	49.74 ± 33.17	0.0024
FSH	0.6 ± 0	0.71 ± 0.25	0.0283	0.74 ± 0.32	0.71 ± 0.26	0.3577
Testosterone	77.45 ± 8.3	90.44 ± 35.96	0.1214	226.53 ± 327.33	185.19 ± 264.04	0.1998
Estradiol	3.17 ± 0.33	2.36 ± 1.17	0.1844	3.02 ± 1.89	2.56 ± 1.61	0.0151
TSH	100.75 ± 23.04	116.56 ± 18.97	0.1397	111.05 ± 21.36	110.45 ± 19.48	0.7671
Thyroxine	1.14 ± 0.18	1.41 ± 0.21	0.0204	1.45 ± 0.32	1.41 ± 0.23	0.1733
T3	62.75 ± 5.44	62.33 ± 10.62	0.9398	60.48 ± 7.41	60.11 ± 8.86	0.6516
Creatinine	25 ± 6.16	23.67 ± 10.46	0.8071	26.89 ± 15.83	24.02 ± 11.3	0.0615
GOT	28.5 ± 15.29	22.93 ± 15.86	0.5155	24.53 ± 16.84	20.13 ± 12.75	0.0078
GPT	77.45 ± 60.89	76.3 ± 70.32	0.9755	47.7 ± 38.39	42.81 ± 29.01	0.1910